{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20210406",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "67000",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/210063Orig1s002ltr.pdf",
              "date": "20210408",
              "type": "Letter"
            },
            {
              "id": "67027",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210063s002lbl.pdf",
              "date": "20210412",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20190819",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "59749",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210063s000lbl.pdf",
              "date": "20190820",
              "type": "Label"
            },
            {
              "id": "59774",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/210063Orig1s000ltr.pdf",
              "date": "20190820",
              "type": "Letter"
            },
            {
              "id": "62137",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/210063Orig1s000TOC.html",
              "date": "20200312",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "10",
          "submission_status": "AP",
          "submission_status_date": "20251121",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "84275",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/210063Orig1s010ltr.pdf",
              "date": "20251124",
              "type": "Letter"
            },
            {
              "id": "84331",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/210063s010lbl.pdf",
              "date": "20251128",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20211112",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "69309",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/210063Orig1s003ltr.pdf",
              "date": "20211115",
              "type": "Letter"
            },
            {
              "id": "69311",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210063s003lbl.pdf",
              "date": "20211115",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA210063",
      "sponsor_name": "AVYXA HOLDINGS",
      "openfda": {
        "application_number": [
          "NDA210063"
        ],
        "brand_name": [
          "CLIGAVYX"
        ],
        "generic_name": [
          "FULVESTRANT"
        ],
        "manufacturer_name": [
          "Avyxa Pharma, LLC"
        ],
        "product_ndc": [
          "83831-159"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAMUSCULAR"
        ],
        "substance_name": [
          "FULVESTRANT"
        ],
        "rxcui": [
          "727762",
          "2745138"
        ],
        "spl_id": [
          "29f2a48e-b9af-486e-bc0c-eab3a1ce0b3c"
        ],
        "spl_set_id": [
          "e20d8ca3-8837-4003-8b01-1ebec342062a"
        ],
        "package_ndc": [
          "83831-159-02"
        ],
        "nui": [
          "N0000175582",
          "N0000000145",
          "N0000000168"
        ],
        "pharm_class_epc": [
          "Estrogen Receptor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Estrogen Receptor Antagonists [MoA]",
          "Selective Estrogen Receptor Modulators [MoA]"
        ],
        "unii": [
          "22X328QOC4"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "CLIGAVYX",
          "active_ingredients": [
            {
              "name": "FULVESTRANT",
              "strength": "250MG/5ML (50MG/ML)"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "SOLUTION",
          "route": "INTRAMUSCULAR",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}